Antihemophilic Factor
In the US, Antihemophilic Factor (antihemophilic factor systemic) is a member of the drug class miscellaneous coagulation modifiers and is used to treat Hemophilia A.
US matches:
- Antihemophilic factor (human)
- Antihemophilic factor (recombinant)
- Antihemophilic factor (recombinant) (plasma/albumin free)
- Antihemophilic factor (recombinant) (plasma/albumin free) (advate)
- Antihemophilic factor (recombinant) (plasma/albumin-free)
- Antihemophilic factor (recombinant) (plasma/albumin-free) (xyntha)
- Antihemophilic factor (recombinant) plasma/albumin free
- Antihemophilic factor/von willebrand factor
- Antihemophilic factor/von willebrand factor (human)
- Antihemophilic factor human
- Antihemophilic factor recombinant
- Antihemophilic factor-von Willebrand factor complex
- Antihemophilic factor Intravenous, Injection
- Antihemophilic factor viii and von willebrand factor complex Intravenous
- Antihemophilic Factor
- Antihemophilic Factor/von Willebrand Factor Complex
- Antihemophilic Factor/von Willebrand Factor Complex (Human)
Ingredient matches for Antihemophilic Factor
Coagulation Factor VIII , Human (rDNA) Octocog Alfa (a derivative of Coagulation Factor VIII , Human (rDNA)) is reported as an ingredient of Antihemophilic Factor in the following countries:
- Israel
International Drug Name Search
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
